Indegene share price today

Indegene Ltd's share price was ₹617.10 at the close on 4 November 2026. It has been rising for 12 weeks. That is 12.8% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹429 and ₹617, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Indegene Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 15 weeks in a row.

Over the last 2.5 years the share price moved +11% while the NIFTY 500 moved +3%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: indian funds and insurers (DIIs) raised their stake for 4 quarters in a row, revenue up on a year earlier for 11 quarters in a row (every quarter we can compare) and highest quarterly revenue in 15 quarters.

1. Indian funds and insurers (DIIs) raised their stake for 4 quarters in a row

   From 7% to 15.8% of the company by the September 2026 quarter.

2. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the September 2026 quarter revenue was ₹1,122 crore, +39.6% on a year earlier.

   Why: Revenue rose because the company won big new contracts and took work from rivals, including a large platform move and new content factory deals.

   Next results: check whether more Tectonic work starts bringing in money as brand teams adopt what central teams ordered.

   From the earnings call on 30 Oct 2026.

3. Highest quarterly revenue in 15 quarters

   Revenue of ₹1,122 crore in the September 2026 quarter is the highest of the last 15 quarters.

For July to September 2026 (the quarter ended 30 September 2026), Indegene reported revenue of ₹1,122 crore, up 39.6% from ₹804 crore a year earlier, and a profit of ₹112 crore, up 9.8% from ₹102 crore.

Indegene results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Indegene's management discussed these results on a call held on 30 October 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Indegene closed at ₹617.10 on 4 November 2026, up 18.0% from ₹523.10 a year earlier (7 November 2025). Its highest weekly close since May 2024 was ₹699.95 on 18 October 2024.

Indegene share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

137 weekly closes from 18 May 2024 to 4 November 2026.

4 Nov 2026: Indegene closed at ₹617.10, up 5.2% on the week and up 4.0% on the month. 30 Oct 2026: Indegene held its results call for July to September 2026. Management guided: Full-year organic growth stronger than last year with established and newer cohorts moving together.

Earlier

• Results for July to September 2026: Revenue up 39.6% and profit up 9.8% on a year earlier.
• 31 Jul 2026: ex-date for a dividend of ₹2.25 a share.

Indegene paid ₹2.25 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.36% at the ₹617.10 close on 4 November 2026. The last was a dividend of ₹2.25 a share, ex-date 31 July 2026.

Indegene dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Indegene Ltd paid out 13% of its profit as dividends in FY26, and it paid a dividend in 2 of its last 8 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for July to September 2026, held on 30 October 2026, Indegene's management guided: Full-year organic growth stronger than last year with established and newer cohorts moving together.

“The value accrues to those who own the domain, data, workflows, and execution. That is the Indegene model.”Manish Gupta, on the call for July to September 2026

What management guided

• Quarterly operating margin above 19% by Q4 this year returning to historical range.
• H2 revenue stronger than H1 on scaling wins and pipeline.
• $10 million ACV outcome contract larger in H2 peaking at Q4 calendar true-up.
• Enterprise Commercial to outpace Enterprise Medical over next 2 quarters.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for July to September 2026, 30 October 2026.

When Indegene reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Large outcome omnichannel true-up at calendar-year threshold into year-end - confirms flagged H2 ramp and margin kicker.

Indegene is on 2 of our India lists: Momentum stocks and Small & mid cap stocks.

Indegene Ltd earned ₹112 Cr of net profit in the Sep 2026 quarter, +9.8% on the same quarter a year earlier. Full-year FY26 profit was ₹401 Cr. Over 7 years profit has grown 61.5% a year on average. That is 10.0% of the quarter's revenue. The same quarter a year earlier earned ₹102 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹401 Cr (−1.5% on the year before).

Why profit moved: revenue changed +39.6% on a year earlier and the margin moved +0.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed −7.2% and revenue +35.7%. Profit is growing slower than sales: rising costs are taking part of the growth.

Indegene Ltd reported ₹1,122 Cr of revenue in the Sep 2026 quarter, +39.6% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 7 years it has grown 30.2% a year on average. The last full year, FY26, came in at ₹3,510 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹4,130 Cr.

FY26 revenue was ₹3,510 Cr, +23.6% on the year before.

Recent pace: the last four quarters grew +35.7% on average, against 30.2% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +35.8%, against +23.5% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −7.8%, against +4.8% a year (rolling over).

Indegene Ltd's operating margin was 17.0% in the Sep 2026 quarter, about the same as the same quarter a year ago. Across 8 years it has been between 8.0% and 24.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

In the latest quarter it moved +0.0 percentage points on the same quarter a year ago.

Why the margin moved: operating margin changed −0.9 percentage points on the year while gross margin changed +0.0 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 140% of Indegene Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹651 Cr of operating cash against ₹401 Cr of profit. After ₹1,268 Cr of spending on assets, free cash was −₹617 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 140% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: the bigger use of cash is spending on new assets, at 5.1× depreciation over three years. The next section checks what that spending is building.

Indegene Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 102 days in FY26, down from 108 days in FY21. It spent ₹1,442 Cr on assets over the last 3 years.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹3,510 Cr, each day of that cycle ties up about ₹9.6 Cr, so roughly ₹981 Cr is tied up in the business at any time.

Spending on assets: ₹1,442 Cr over the last 3 years, against ₹282 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹12.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Indegene Ltd's P/E is 34.9×, in the middle of its own history: higher than 64% of past readings. Its usual P/E (the middle reading) is 32.8×, over 2.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹17.07.

Why the multiple is where it is: over the past year earnings per share moved −1.8% while the price moved +18.0%. The price did better than earnings, which pushed the multiple up within its own range.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

Indegene Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −7.8% in the latest quarter, against +34.5% at its best in 12 quarters, with ROCE falling at 17.1%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Indegene Ltd earned a ROCE of 19% in FY26. Its return on capital used (ROIC) is 7.3 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 11.4% net margin and 0.76× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 11.4% net margin × 0.76× asset turnover × 1.47× leverage (assets divided by equity) ≈ 12.7% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 19.3% − 12.0% = +7.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value.

The 19.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 26.5%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Indegene Ltd has total debt of ₹157 Cr against shareholder equity of ₹3,358 Cr as of Sep 2026, so its debt is 0.05× its equity, which is very little. Year by year, that ratio went from 0.47 in FY23 to 0.05 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Domestic institutions raised their stake in Indegene Ltd by 12.7 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 15.8% of the company. Foreign institutions moved +7.6 points over the same period, to 12.4%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Why the owners changed: domestic institutions drove it (+12.7 points), together with foreign institutions (+7.6 points). They raised their stake step by step.

For Indegene Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

62.6 out of 100, rank 1 of 8 in Services - Others, with 93% of the evidence available.

Indegene Ltd scores 62.6 out of 100 against the 8 companies it is compared with in Services - Others, ranking 1. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 17.7 + 18 + 8.5 + 18.4 = 62.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Indegene ranks 1 of 8 Services - Others companies on the 4-Factor Sector Score, with 62.6 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Services - Others, all 8 compared on one page.

Indegene is the largest of 8 Services - Others companies on Sector Alpha by market value (scores of 30 October 2026). It is the largest. Just below it: BLS International Services, PDS, CMS Info Systems, eMudhra, Team Lease Services and Kapston Services.

Services - Others companies close in size

1. Indegene Ltd ₹14,141 crore
2. BLS International Services Ltd ₹8,614 crore
3. PDS Ltd ₹5,690 crore
4. CMS Info Systems Ltd ₹3,283 crore
5. eMudhra Ltd ₹2,815 crore
6. Team Lease Services Ltd ₹1,651 crore
7. Kapston Services Ltd ₹1,490 crore

All 8 Services - Others companies, largest first

Companies close in size in other industries

468. Engineers India Ltd ₹14,155 crore · Infra - Engineering - General
469. Black Box Ltd ₹14,150 crore · Data Centre
470. Indegene Ltd ₹14,141 crore
471. Century Plyboards (India) Ltd ₹14,117 crore · Plywood Boards/Laminates
472. Vardhman Textiles Ltd ₹14,078 crore · Textiles - Spinning

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.